false
English
Catalog
2021 World Conference on Lung Cancer (Posters)
P29. Evaluation of the Prognostic Marker of PD-L1 ...
P29. Evaluation of the Prognostic Marker of PD-L1 Expression After Combined Radiochemotherapy in Patients With NSCLC Stage III
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
Jan Wagner, a medical student, presents the results of a study on the prognostic marker of PD-L1 expression after combined radiochemotherapy in NSCLC Stage 3. The study aims to test the hypothesis that PD-L1 expression can be a prognostic factor. The study used clinical data and characteristics from a tumor database, with 99 patients included. The study found that there was no significant difference in overall survival and progress-free survival based on PD-L1 expression. The study suggests that PD-L1 expression may not reliably predict prognosis and recommends further studies with a larger patient collective.
Asset Subtitle
Jan Wagner
Meta Tag
Speaker
Jan Wagner
Topic
Locally Advanced Non-Small Cell Lung Cancer
Keywords
PD-L1 expression
prognostic marker
combined radiochemotherapy
NSCLC Stage 3
clinical data
×
Please select your language
1
English
5
普通话
11
Dutch